Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Hruby

Showing results (11-20 of 121) with videos related to

Pageof 13
Sort By:
Pharmaceutical Research|April 1, 1987
Use of vaccinia virus to express biopharmaceutical productsD E Hruby, G Thomas
The Journal of Biological Chemistry|October 15, 1990
Identification of the ATP-binding domain of vaccinia virus thymidine kinaseM E Black, D E Hruby
Biochimica Et Biophysica Acta|June 11, 1993
Further characterization of an adenosine-containing modification of vaccinia virus proteinsS J Child, D E Hruby
Methods in Enzymology|January 1, 1992
Use of fluorescent chloramphenicol derivative as a substrate for chloramphenicol acetyltransferase assaysD E Hruby, E M Wilson
The Journal of General Virology|June 1, 1994
Characterization of the vaccinia virus L1R myristylprotein as a component of the intracellular virion envelopeM P Ravanello, D E Hruby
Journal of Virology|August 1, 1977
Encephalomyocarditis virus RNA. II. Polyadenylic acid requirement for efficient translationD E Hruby, W K Roberts
Archives of Virology|January 1, 1987
Association of non-viral proteins with recombinant vaccinia virus virionsC A Franke, D E Hruby
Virology|September 1, 1981
Cell-free synthesis of enzymatically active vaccinia virus thymidine kinaseD E Hruby, L A Ball
Journal of Virology|May 30, 1998
Analysis of a vaccinia virus mutant expressing a nonpalmitylated form of p37, a mediator of virion envelopmentD W Grosenbach, D E Hruby
The Journal of Biological Chemistry|April 5, 1992
Site-directed mutagenesis of a conserved domain in vaccinia virus thymidine kinase. Evidence for a potential role in magnesium bindingM E Black, D E Hruby
Pageof 13

Showing results (11-20 of 121) with videos related to

Sort By:
Pageof 13
Pharmaceutical Research|April 1, 1987
Use of vaccinia virus to express biopharmaceutical productsD E Hruby, G Thomas
The Journal of Biological Chemistry|October 15, 1990
Identification of the ATP-binding domain of vaccinia virus thymidine kinaseM E Black, D E Hruby
Biochimica Et Biophysica Acta|June 11, 1993
Further characterization of an adenosine-containing modification of vaccinia virus proteinsS J Child, D E Hruby
Methods in Enzymology|January 1, 1992
Use of fluorescent chloramphenicol derivative as a substrate for chloramphenicol acetyltransferase assaysD E Hruby, E M Wilson
The Journal of General Virology|June 1, 1994
Characterization of the vaccinia virus L1R myristylprotein as a component of the intracellular virion envelopeM P Ravanello, D E Hruby
Journal of Virology|August 1, 1977
Encephalomyocarditis virus RNA. II. Polyadenylic acid requirement for efficient translationD E Hruby, W K Roberts
Archives of Virology|January 1, 1987
Association of non-viral proteins with recombinant vaccinia virus virionsC A Franke, D E Hruby
Virology|September 1, 1981
Cell-free synthesis of enzymatically active vaccinia virus thymidine kinaseD E Hruby, L A Ball
Journal of Virology|May 30, 1998
Analysis of a vaccinia virus mutant expressing a nonpalmitylated form of p37, a mediator of virion envelopmentD W Grosenbach, D E Hruby
The Journal of Biological Chemistry|April 5, 1992
Site-directed mutagenesis of a conserved domain in vaccinia virus thymidine kinase. Evidence for a potential role in magnesium bindingM E Black, D E Hruby
Pageof 13